Related Experiment Video

Updated: May 3, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

17.8K

Strategy of Daiichi Sankyo discovery research in oncology

Kouichi Akahane1, Kazunori Hirokawa

  • 1*Shinagawa R&D Center, Daiichi Sankyo Co., Ltd, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. akahane.koichi.c8@daiichisankyo.co.jp.

Japanese Journal of Clinical Oncology
|January 25, 2014
PubMed

Insights

Daiichi Sankyo focuses on innovative cancer targeted medicines, developing 14 clinical projects and leveraging global research collaborations. Their strategy targets cancer cell growth and survival signals to overcome drug resistance.

Area of Science:

  • Oncology
  • Pharmaceutical Drug Discovery

Background:

  • Daiichi Sankyo is actively developing targeted cancer therapies.
  • The company has 14 clinical projects underway, with three drugs already approved.
  • Current therapies primarily target cancer cell growth and survival pathways.

Purpose of the Study:

  • To outline Daiichi Sankyo's comprehensive strategy for developing innovative cancer targeted medicines.
  • To highlight the company's global discovery efforts and external research collaborations.
  • To emphasize the focus on personalized medicine for improved cancer treatment.

Main Methods:

  • Implementing a drug discovery strategy focused on targeted therapies.
  • Conducting global research and development activities across multiple sites (Japan, EU, USA).
  • Facilitating external research collaborations with academic institutions and scientists.

Main Results:

  • Development of 14 clinical projects for cancer treatment, including three approved drugs.
  • Focus on selective inhibitors targeting key cancer cell signaling pathways.
  • Establishment of diverse research expertise through international collaboration.

Conclusions:

  • Daiichi Sankyo is committed to advancing targeted cancer therapies.
  • The company aims to overcome drug resistance through rational combination strategies.
  • Future efforts will prioritize the development of innovative personalized medicines for cancer patients.
Keywords:
Daiichi Sankyodrug discoverytargeted medicine

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Author Spotlight: Standardized Herbal Decoction Protocol for Enhanced Animal Studies03:11

Author Spotlight: Standardized Herbal Decoction Protocol for Enhanced Animal Studies

Published on: June 7, 2024

1.9K

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K